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DNA damage triggers polyubiquitylation and degra-
dation of the largest subunit of RNA polymerase II
(RNAPII), a ‘‘mechanism of last resort’’ employed
during transcription stress. In yeast, this process is
dependent on Def1 through a previously unresolved
mechanism. Here, we report that Def1 becomes
activated through ubiquitylation- and proteasome-
dependent processing. Def1 processing results in
the removal of a domain promoting cytoplasmic
localization, resulting in nuclear accumulation of the
clipped protein. Nuclear Def1 then binds RNAPII,
utilizing a ubiquitin-binding domain to recruit the
Elongin-Cullin E3 ligase complex via a ubiquitin-
homology domain in the Ela1 protein. This facilitates
polyubiquitylation of Rpb1, triggering its protea-
some-mediated degradation. Together, these results
outline the multistep mechanism of Rpb1 polyubi-
quitylation triggered by transcription stress and
uncover the key role played by Def1 as a facilitator
of Elongin-Cullin ubiquitin ligase function.
INTRODUCTION
Substantial research effort is presently focused on understand-
ing the cellular processes maintaining genome integrity and
allowing faithful replication after DNA damage (Branzei and
Foiani, 2010). Although such processes are of utmost impor-
tance for the long-term survival and fitness of cells and organ-
isms, the key immediate response of cells suffering genotoxic
insult is arguably to maintain gene expression. Indeed, without
continued transcription, cells cannot proceed through the cell
cycle, and even nondividing cells will perish. Like DNA replica-tion, transcription is severely affected by DNA damage, with
various DNA lesions resulting in RNAPII stalling, pausing, arrest,
and/or backtracking (hereafter collectively referred to as tran-
scription stress). It is therefore not surprising that cells have
evolved a number of mechanisms to ensure that transcription
can rapidly resume upon DNA damage (Svejstrup, 2010). One
important mechanism is transcription-coupled nucleotide exci-
sion repair (TC-NER), which removes transcription-blocking
lesions so that RNAPII can continue (Gaillard and Aguilera,
2013). In budding yeast, TC-NER is dependent on Rad26, the
homolog of human Cockayne syndrome B (van Gool et al.,
1994). Intriguingly, Rad26 interacts with another protein, Def1
(Woudstra et al., 2002). The phenotypes of cells lacking DEF1
indicate a role for this factor in the DNA damage response, but
Def1 is not involved in repair. Instead, it is required for a ‘‘mech-
anism of last resort.’’ During this alternative process, the largest
subunit of RNAPII, Rpb1, becomes ubiquitylated and degraded,
which results in disassembly of the large RNAPII complex and
allows the lesion to be dealt with by other means (Wilson et al.,
2013). Although it was originally identified as a response to
DNA damage (Bregman et al., 1996; Beaudenon et al., 1999), it
is now known that Rpb1 ubiquitylation and degradation occurs
under a number of conditions that result in transcription stress
(Hobson et al., 2012; Somesh et al., 2005; Sigurdsson et al.,
2010). Obviously, Rpb1 ubiquitylation must be tightly regulated
to specifically target the small subset of elongating polymerases
that cannot otherwise be salvaged, as any unnecessary Rpb1
degradation will severely affect general gene expression and
cell survival. Results obtained over the last decade have pro-
vided insight into the mechanisms by which Rpb1 is ubiquity-
lated and degraded (reviewed in Wilson et al., 2013), but
although it is required for Rpb1 ubiquitylation, the precise role
of Def1 has remained elusive.
Degradation of Rpb1 occurs by the addition of lysine 48-
linked polyubiquitin chains, disassembly of the chromatin-
associated RNAPII elongation complex, and proteasomalCell 154, 983–995, August 29, 2013 ª2013 The Authors 983
Figure 1. Def1 Is Processed in Response to
Transcription Stress
(A) Schematic representation of Def1 indicating
the CUE domain, area of processing (arrow), and
glutamine rich region.
(B) Western blot of cell extracts at the indicated
times after UV irradiation, using antibodies against
Rpb1, Def1, and Pgk1 (loading control).
(C) As in (B), but after incubation with 4-nitro-
quinoline 1-oxide (4-NQO).
(D) Def1 processing induced by 6-azauracil (6-AU).
Superfluous lanes between lanes 4 and 5 were
removed.
(E) As in (B), but ubiquitylated proteins isolated
using MultiDsk pull-down (Wilson et al., 2012).
(F) Western blot probed using anti-Def1 antibody,
showing WT, or N-terminally 9xMyc-tagged Def1
(left), or WT, or C-terminally 6xHA-tagged Def1
(right), after incubation with 4-NQO for 1 hr.
(G) Western blots of identical samples fromDdef1,
WT, or DEF1-3xHA, probed with anti-Def1 anti-
bodies (left panel), or anti-HA antibodies (right).
See also Figure S1 and Tables S1 and S2.degradation (Wilson et al., 2013). Notably, ubiquitylation of Rpb1
is a two-step process, involving distinct ubiquitin ligases (E3s)
(Harreman et al., 2009). Briefly, stalled RNAPII in budding yeast
is targeted by a HECT domain E3, Rsp5 (Beaudenon et al.,
1999), which cooperates with Uba1 (E1, ubiquitin-activating
enzyme) and Ubc5 (E2, ubiquitin-conjugating enzyme) to add a
single ubiquitin moiety, probably at more than one site on
Rpb1 (Somesh et al., 2007; Harreman et al., 2009). A second
E3 ligase, a complex containing the Elc1, Ela1, Cul3, and
Rbx1 proteins (‘‘Elongin-Cullin complex’’), then takes over and
adds lysine 48-linked ubiquitin chains to the premonoubi-
quitylated Rpb1 (Harreman et al., 2009; Ribar et al., 2006,
2007). Following polyubiquitylation, a ubiquitin-specific
ATPase, Cdc48, then delivers Rpb1 from the RNAPII elongation
complex to the proteasome (Verma et al., 2011). The mechanism
of Rpb1 ubiquitylation is highly conserved, with the process in
mammals being catalyzed by NEDD4 and the Elongin ABC-
Cullin 5 complex, homologs of the budding yeast E3 proteins
(Huibregtse et al., 1997; Anindya et al., 2007; Yasukawa et al.,
2008; Harreman et al., 2009).
As mentioned above, polyubiquitylation and degradation
of Rpb1 also requires the Def1 protein, both in vivo (Woudstra
et al., 2002) and in vitro (Reid and Svejstrup, 2004). Def1 is
an unusual protein, consisting largely of domains of low
complexity, with a predicted N-terminal CUE (ubiquitin-binding)984 Cell 154, 983–995, August 29, 2013 ª2013 The Authorsdomain as the only notable feature
(Ponting, 2002) (Figure 1A). In this study,
we show that ubiquitylation and degrada-
tion of Rpb1 encompasses an unusually
wide variety of ubiquitin-related mecha-
nisms centered on the Def1 protein.
Together, these mechanisms facilitate
nuclear accumulation of a proteasome-
processed version of Def1, which then
acts as a bridging factor betweenRNAPII and the Elongin-Cullin complex, triggering Rpb1
polyubiquitylation.
RESULTS
Def1 Is Processed in Response to DNA Damage and
Other Transcription Stress
Under conditions that generate transcription-impeding DNA
damage, such as UV irradiation and treatment with 4-nitroquino-
line 1-oxide (4-NQO), we noticed the appearance of a faster
migrating protein, hereafter called processed Def1 (pr-Def1),
which specifically cross-reacted with a Def1 antibody (Figures
1B, 1C, and 1G, left, and Figure S1A available online). The faster
migrating Def1 form was also observed upon treatment with the
transcription elongation inhibitor, 6-azauracil (6-AU) (Figure 1D),
suggesting that it is generated in response to transcription
stress, rather than as a damage response per se. pr-Def1 forma-
tion correlated with polyubiquitylation (Figure 1E) and degrada-
tion (Figures 1B and 1C) of Rpb1.
Three distinct processesmight theoretically explain the gener-
ation of pr-Def1. First, it might be caused by changes in the pro-
duction ofDEF1mRNA (e.g., alternative start- or stop-site usage
or alternative splicing). Second, it might be caused by changes in
mRNA translation. Third, it might occur at a posttranslational
stage, via partial proteolysis. No significant changes in the
Figure 2. Processing of Def1 Produces an
Activated Form
(A) Dilution growth series of cells expressing Def1
fragments.
(B) A ratio of 2:2 segregation of spores from
four different tetrads from a heterozygous DEF1/
def11–500::HIS3 diploid, with spore genotype indi-
cated. Viable HIS3 colonies were never observed.
(C) Dilution series of Ddef1 yeast cells (with GAL-
driven plasmid indicated on left), grown on
glucose or galactose. Overexpression of WTDEF1
from a 2 mm plasmid is slightly detrimental to
Ddef1 cells.
(D) Western blot showing Def1 from 4-NQO-
treated WT cells, and def11–530, respectively.
(E) Western blot of extract from cells expressing
Myc-tagged TEV protease, as well as WT Def1, or
Def1 containing a TEV protease cleavage site.
Blots of ubiquitylated proteins shown in two upper
panels, with extract blots shown below. Lanes 1
and 2 were underloaded, giving the false impres-
sion that growth in galactose results in higher
Rpb1 monoubiquitylation. Superfluous lanes be-
tween lanes 5 and 6 were removed.
(F) Western blots of extracts from WT and
def11–530 cells grown at permissive (25
C) or
restrictive temperature (37C). Rpb1 signal was
quantitated relative to the Pgk1 control, and the
values at time 0 set to 100; other values are
expressed relative to that. Superfluous lanes
between lanes 6 and 7 were removed.
See also Figure S2.production of DEF1 mRNA were detectable in response to DNA
damage (Figure S1B), and pr-Def1 was still generated in
response to DNA damage in cells that no longer produced new
Def1 protein (Figure S1C). This indicates that Def1 processing
is a posttranslational event, a conclusion that was further sup-
ported by all subsequent experiments.
To investigate whether it is the N or C terminus of Def1 that is
missing from pr-Def1, yeast strains expressing tagged versions
of Def1 were generated. When N-terminally tagged Def1 was
detected using the polyclonal anti-Def1 antibody, the processed
version was larger than wild-type (WT) pr-Def1 (Figure 1F, left),
whereas no mobility shift of pr-Def1 was observed when a HA-
tag was positioned at the (degraded) C terminus (Figure 1F,
right). Indeed, Def1, but not pr-Def1, could be detected with
anti-HA antibody (Figure 1G, compare lanes 6 and 12). Together,
these experiments demonstrate that pr-Def1 lacks the C-termi-
nal region of full-lengthDef1. This short fragment has persistently
evaded detection, suggesting that it is degraded during process-
ing, or immediately thereafter.
Processing of Def1 Produces an Activated Form
If pr-Def1 plays a causative role in the response to transcription
stress, it might be expected that artificial generation of pr-Def1-
like protein species would result in Def1 activation and possibly
lead to Rpb1 ubiquitylation and degradation. To address this
possibility, the endogenous DEF1 gene was shortened by
genomic recombination. Small C-terminal deletions (generating
Def11–600 and Def11–700) had little or no effect on cell growth,
whereas large deletions (generating Def11–100 to Def11–300)resulted in a slow-growth phenotype, similar to that of a com-
plete DEF1 deletion (Figure 2A). Strikingly, haploid strains
expressing Def11–400 and Def11–500 (that would theoretically
encode protein fragments of a size similar to that of pr-Def1)
could not be generated despite repeated attempts, but a diploid
strain expressing both WT Def1 and Def11–500 was viable. How-
ever, upon sporulation and tetrad dissection of this diploid into
haploid spores, only two of four spores were viable; these con-
tained the WT version of DEF1 (Figure 2B), indicating that the
Def11–500 fragment is toxic. Def1 self-associates (Figure S2A)
and might be either a dimer or a multimeric protein. This could
explain why the expression of genetically truncated versions of
Def1 is not lethal when a WT copy of DEF1 is also present. In
apparent agreement with this idea, other proteolytically pro-
cessed proteins have been reported to be dimeric (Rape and
Jentsch, 2002).
Expression of Def11–400 and Def11–500 proteins from an induc-
ible promoter also inhibited cell growth, whereas expression of
WT Def1 and Def11–600 had little or no effect (Figure 2C, galac-
tose). Together, these data indicate that expression of geneti-
cally generated, shorter forms of Def1 that mimic pr-Def1 is
strongly detrimental to the cell.
Repeated attempts to map the site of damage-induced Def1
processing by mass spectrometric analysis proved unsuccess-
ful. As an alternative approach to better define processing, we
therefore used genetic recombination to generate C-terminal
DEF1 deletions in the equivalent of ten amino acid intervals
between Def1 residues 500 and 600. DEF1 genes expressing
proteins between 500 and 520 amino acids in length were lethal,Cell 154, 983–995, August 29, 2013 ª2013 The Authors 985
Figure 3. Proteasome- and Ubiquitin-
Dependent Def1 Processing
(A) Western blot of extracts from cells treated with
(or without) MG132 prior to incubation with 4-NQO
for the indicated times.
(B) Left: Def1 processing reconstituted using pure
Def1 and 26S proteasome (see Figure S3A), and
its sensitivity to MG132. Right: western blot
comparing pr-Def1 with Def1 processed by pure
proteasome.
(C) Western blot of extract from WT and rsp5-1
cells grown at 37C for 2 hr before addition of 4-
NQO for the indicated times. Lanes 4 and 5 are
underloaded, giving the false impression that Def1
disappears at those time points. Normal pro-
cessing was observed in rsp5-1 at the permissive
temperature (data not shown).
(D) Western blots of Def1 ubiquitylation, recon-
stituted using highly purified proteins (Def1, ubiq-
uitin,Uba1,Ubc5,Rsp5,andUbp2; seeFigureS3A).
(E) Western blots of ubiquitylated proteins (upper
three panels) and extracts (input; lower three
panels) from UV-irradiated WT and Def1 ubiq-
uitylation site mutant (4xUbm) cells, respectively.
See also Figure S3.whereas those generating Def1 proteins of 530 amino acids or
more were viable (Figure S2B). Interestingly, a strain expressing
Def11–530 (def1–530) was temperature-sensitive (Figure S2C). This
version of the Def1 protein migrated slightly slower than pr-Def1
(Figure 2D), suggesting that the natural processing site lies
somewhere in the region prior to amino acid 530. We attempted
to disrupt Def1 processing by making internal deletions in this
region, but these merely resulted in shifting the site to another
position (Figure S2D). This suggests that Def1 processing
does not occur at a specific, short amino acid motif, as has
also been found for other processed proteins (Piwko and
Jentsch, 2006).
To investigate whether Def1 clipping in itself can trigger
RNAPII ubiquitylation even in the absence of transcription stress,
we now constructed a yeast strain expressing Def1 with a
tobacco etch virus (TEV) protease cleavage site inserted be-
tween amino acids 522 and 523, around the predicted region
of normal processing. Such modification had no obvious effect
on DEF1 function (Figure S2E). Upon induction ofGAL-regulated
Myc-TEV protease (Figure 2E, third panel from bottom), a frac-
tion of Def1 was indeed cleaved, but only in the strain with the
inserted TEV site (pr*-Def1; Figure 2E, second panel from bot-
tom). Importantly, a fraction of Rpb1 reproducibly became poly-
ubiquitylated concurrently with the emergence of pr*-Def1
(Figure 2E, top, compare lanes 9 and 10 with 4 and 5, respec-
tively). These results indicate that Def1 processing can in itself
trigger detectable Rpb1 polyubiquitylation, independently of
DNA damage. Not surprisingly, the effect of TEV-induced cleav-
age was less pronounced than after DNA damage and did not
result in appreciable degradation of the Rpb1 protein, presum-986 Cell 154, 983–995, August 29, 2013 ª2013 The Authorsably because TEV-mediated Def1 nicking
does not induce other pathways that are
activated by transcription stress.Next, the temperature-sensitive def11–530 strain was used to
further investigate the effect of Def1 processing. We surmised
that because def11–530 is slow growing at 37
C, the restrictive
temperature likely activates this version of Def1. Overall protein
levels and that of the Pgk1 control protein remained largely un-
changed at 37C. In contrast, Rpb1 protein levels decreased
with time in def11–530, but notWT cells (Figure 2F, compare lanes
11 and 12 with 5 and 6), again suggesting that the processed
version of Def1 triggers RNAPII ubiquitylation and degradation.
Def1 Is Processed in a Ubiquitin- and Proteasome-
Dependent Manner
Ubiquitin- and proteasome-dependent protein processing,
whereby a part of a protein is degraded to release a biologically
active fragment, has been described for other proteins (reviewed
in Rape and Jentsch, 2002). In agreement with a similar role for
the proteasome in the processing of Def1, treatment of yeast
cells that are sensitized to proteasome inhibitor (Collins et al.,
2010) with MG132 inhibited the formation of pr-Def1 (Figure 3A).
In order to test whether the proteasome can directly process
Def1, we reconstituted proteasomal processing in vitro using
Def1 and 26S proteasome purified to virtual homogeneity (Fig-
ure S3A). Strikingly, in this simple assay correct proteasome-
dependent Def1 processing was observed, with full-length
Def1 processed to the shortened version (Figure 3B, lanes 5
and 6). As expected, this was greatly reduced in the presence
of proteasome inhibitor (lanes 2 and 3). Significantly, pr-Def1
was not proteolyzed further: smaller proteolysis products were
not observed, and the overall Def1 protein amount remained
constant. Moreover, the size of processed Def1 generated by
purified proteasome in vitro was similar to that of pr-Def1 gener-
ated by transcription stress in vivo (Figure 3B, right panel,
compare lanes 2 and 3).
Not all proteasome-mediated protein degradation requires
ubiquitylation of the target protein (Jariel-Encontre et al., 2008).
However, in other reported cases of proteasomal protein pro-
cessing, ubiquitylation of the target protein has been implicated,
at least in vivo (Palombella et al., 1994; Hoppe et al., 2000; Pan
et al., 2006). Moreover, monoubiquitylation of NF-kB p105 is
sufficient for its proteasomal processing (Kravtsova-Ivantsiv
et al., 2009), and we recently found that Def1 becomes monou-
biquitylated in response to DNA damage (Wilson et al., 2012).
The ubiquitin ligase Rsp5 binds and monoubiquitylates Rpb1
(Huibregtse et al., 1997; Harreman et al., 2009). Furthermore,
this E3 has been implicated in proteasomal processing of other
yeast proteins (Hoppe et al., 2000). We therefore investigated
whether Rsp5 might be involved in Def1 ubiquitylation and pro-
teasomal processing. Indeed, in a strain carrying a tempera-
ture-sensitive rsp5 allele, Def1 failed to be efficiently processed
in response to 4-NQO at the restrictive temperature (Figure 3C,
middle panel on right), whereas Def1 processing and accompa-
nying Rpb1 degradation was observed in the WT control strain
(Figure 3C, left). The remaining proteasomal processing of
Def1 observed in this experiment might be explained by residual
Rsp5 activity at the restrictive temperature, or by ubiquitylation
merely playing a stimulatory role in Def1 processing.
To ascertain whether Rsp5 can directly ubiquitylate Def1, we
reconstituted the process with highly purified proteins. Def1
ubiquitylation was indeed observed upon incubation with Uba1
(E1), Ubc5 (E2), and ubiquitin, but only when active Rsp5 was
included (Figure 3D, lane 5). Ubiquitylation was not observed
when the active site of Rsp5 was mutated (lane 4), or in the pres-
ence of ubiquitin protease Ubp2 (lane 6), which associates with
Rsp5 in vivo (Kee et al., 2005).
Using Def1 that had been ubiquitylated in vitro, two pairs of
adjacent, potential ubiquitylation sites were now identified by
mass spectrometry. Simultaneous mutation of these four sites
(K281R, K288R, K328R, K329R; creating 4xUbm) resulted in
strongly reduced Def1 ubiquitylation and perturbed Rpb1 poly-
ubiquitylation, (Figure 3E, upper panels, compare lanes 3 and
4) and also affected Def1 processing and Rpb1 degradation (Fig-
ure 3E, lower panels), in response to DNA damage. Interestingly,
4xUbm did not always completely abrogate Def1 processing
(see Figure S3B). This suggests that other potential ubiquityla-
tion sites still remain available, or that proteasomal processing
of Def1 is only accelerated by ubiquitylation, but not absolutely
dependent on it, in apparent agreement with the results obtained
in rsp5-1 (Figure 3C). Furthermore, ubiquitylation of Def1 was not
absolutely required for proteasomal processing in the reconsti-
tuted in vitro system, although it could accelerate the process
(Figure S3C).
Taken together, these results strongly indicate that processing
of Def1 involves Rsp5-mediated ubiquitylation and partial degra-
dation by the proteasome.
pr-Def1 Accumulates in the Nucleus
The experiments above indicate that proteasomal processing
activates Def1, but how pr-Def1 promotes polyubiquitylation ofRpb1 remained unclear. We began to characterize this connec-
tion by examining the cellular localization of Def1. Previous
studies indicated that Def1 is cytoplasmic (Huh et al., 2003;
Tkach et al., 2012), despite being required for Rpb1 polyubiqui-
tylation in chromatin (Woudstra et al., 2002; Verma et al., 2011).
However, the earlier localization studies relied on a C-terminal
GFP-tag on Def1, which would not visualize pr-Def1. By using
an N-terminal GFP-tag on Def1 instead, we ensured that both
forms of Def1 could be detected. Without UV treatment, GFP-
Def1 was cytoplasmic, as expected (Figure 4A, panels c and f).
After treating yeast cells with UV light, however, the GFP signal
spread across the entire cell, including the DAPI-stained nucleus
(Figure 4A, panels i and l). In contrast, C-terminally tagged Def1-
GFP did not show relocalization after treatment with UV (Figures
4B and S4A).
Def1 was also GFP-tagged in the MG132-sensitized strain
(Collins et al., 2010). When these cells were treated with protea-
some inhibitor to block pr-Def1 formation, Def1 remained in the
cytosol even after DNA damage (compare Figure 4C, panel f,
with 4A, panel i), further indicating that only pr-Def1 accumulates
in the nucleus.
It was now investigated whether altering steady-state sub-
cellular localization might suppress the previously described
toxicity of GAL-expressed Def11-500. Indeed, even though
Def11–500 was overexpressed, appending a prototypical
leucine-rich nuclear export signal (NES) (Gerace, 1995) to its N
terminus reproducibly decreased toxicity (Figure 4D), suggesting
that the detrimental effect of Def11–500 expression is at least
partly due to nuclear localization.
We next examined whether the C-terminal region of Def1
might harbor a domain, which directly or indirectly leads to
cytoplasmic localization by either inhibiting nuclear import or
promoting nuclear export (Figure 4E). When a GFP control pro-
tein containing both a nuclear localization signal (NLS) and an
NES was expressed, the fusion-protein was detected in the
whole cell (Figure 4E, panels a–c) (Taura et al., 1998). In contrast,
if the GFP construct contained an NLS, but lacked the NES and
instead carried a C-terminal control domain (b-galactosidase), it
was exclusively nuclear (Figure 4E, panels g–i) (Lee et al., 1996).
Importantly, when this control domain was replaced with the
Def1 C terminus (amino acids 500–738), the resulting GFP fusion
protein was found in both the nucleus and the cytoplasm (Fig-
ure 4E, panels m–o), showing that the C terminus of Def1 pro-
motes cytoplasmic localization.
Although the best-characterized mechanism of nuclear export
occurs via NESs recognized by the Crm1 receptor (Hutten and
Kehlenbach, 2007), 13 additional members of the karyopherin
family of nuclear transport receptors are found in Saccharo-
myces cerevisiae (Stro¨m and Weis, 2001). For the vast majority
of these receptors, the motif targeting the cargo for transport
has not been defined. However, export from the nucleus is typi-
cally dependent on components of the nuclear pore, such as
Rat7 (Nup159) (Brykailo et al., 2007 and references therein).
The Def1 C-terminal domain does not contain a classical NES
motif, and as expected, Def1 indeed remained cytoplasmic
when Crm1 was inhibited (Figure S4B). Importantly, however,
the C-terminal domain of Def1 failed to bring about cytoplasmic
localization and thus accumulated in the nucleus in the nuclearCell 154, 983–995, August 29, 2013 ª2013 The Authors 987
Figure 4. pr-Def1 Accumulates in the Nucleus
(A) Subcellular localization of N-terminally GFP-tagged Def1 after UV irradiation. Nucleus is marked by DAPI staining. Left: a typical field of cells. Right:
enlargement of the yeast cell indicated by white box in panel on left. The number and size of vacuoles differed from experiment to experiment, but it had no
influence on the nuclear accumulation observed.
(B) Quantification of damage-induced, nuclear accumulation of N-terminally tagged GFP-Def1 and C-terminally tagged Def1-GFP, respectively. Error bars
indicate SD of three biological replicates, counting 200–300 cells for each condition.
(legend continued on next page)
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pore mutant rat7-1 (Figure 4E, panels p–r), opening the possibil-
ity that this Def1 domain works by promoting export from the nu-
cleus rather than by inhibiting nuclear import.
Together, these data indicate that Def1 is normally efficiently
exported from the nucleus so that it is mainly cytoplasmic at
steady state. Upon DNA damage or other transcriptional stress,
however, a region directing cytoplasmic localization is removed
by proteolysis, allowing pr-Def1 to accumulate in the nucleus,
facilitating Rpb1 ubiquitylation/degradation.
The CUE Domain Is Critical for Def1 Function
The data above indicate that transcription stress induces protea-
somal Def1 processing, leading to pr-Def1 accumulation in the
nucleus. However, the role of Def1 in Rpb1 ubiquitylation inside
the nucleus remained to be established. We began by examining
the role of the N-terminal CUE domain (Ponting, 2002), predicted
to bind ubiquitin (Shih et al., 2003). Indeed, Def1’s CUE domain
bound to ubiquitin in vitro and when four key CUE residues were
mutated (Shih et al., 2003) (Figure 5A, schematic) it reduced such
binding (Figure S5A; see also Figure 6D). Strikingly, although
expression of Def11–500 was highly toxic, CUE domain mutation
effectively suppressed this effect (Figure 5A). CUE mutation also
abrogated DNA damage-induced Rpb1 polyubiquitylation (Fig-
ure 5B, upper panel; compare lanes 4 and 8). This was not due
to a lack of Def1 activation: CUE mutation had no effect on
Def1 processing (Figure 5B, middle panel) or on its accumulation
in the nucleus (Figure S5B).
Together, these results indicate that the ubiquitin-binding CUE
domain is critical to the nuclear function of pr-Def1.
pr-Def1 Associates with Ela1-Elc1 Complex via Its CUE
Domain
Rpb1 is monoubiquitylated by Rsp5 in a Def1-independent
manner and then polyubiquitylated by the Elongin-Cullin com-
plex in a Def1-dependent fashion (Woudstra et al., 2002; Harre-
man et al., 2009). Consequently, the data presented abovemight
be explained if Def1 helps mediate the interaction of monoubi-
quitylated polymerase with the Elongin-Cullin complex. In this
model, Def1 would use its CUE domain to bind monoubiquity-
lated RNAPII, the Elongin-Cullin complex, or both.
We first performed coimmunoprecipitation experiments using
extracts fromUV-irradiated yeast cells. RNAPII and the Ela1 sub-
unit of the Elongin-Cullin complex both coimmunoprecipitated
with Myc-Def1 (Figure 5C, lane 5). Somewhat unexpectedly,
however, mutation of the Def1 CUE domain had little or no effect
on the interaction with RNAPII, but resulted in a reproducible
decrease in the interaction with Ela1 (compare lanes 5 and 9).
To further analyze the intriguing interaction between Def1 and
Elongin-Cullin complex, the same factors were now immunopre-
cipitated from a strain expressing a Myc-tagged version of the
Elc1 protein. Myc-Elc1 coprecipitated Def1, but only if Def1
had a functional CUE domain (Figure 5D, compare lanes 3 and(C) Localization of GFP-Def1 in cells incubated with MG132 for 1 hr prior to UV irr
(D) Dilution series of Ddef1 cells (carrying the GAL-driven CEN plasmid indicated
(E) Localization of GFP in fixed cells expressing NLS-NES-GFP2 (panels a–f), NLS-
cells (left), or rat7-1 cells (right).
See also Figure S4.7). Notably, Myc-Elc1 also failed to coprecipitate RNAPII unless
Def1 had a functional CUE domain, indicating that Def1 is
required to bridge the interaction of Elongin-Cullin with RNAPII.
Ela1 and Elc1 form a heterodimer, akin to the F-box/Skp1 sub-
strate adaptor of other Cullin ligases (Koth et al., 2000), which we
now produced in Escherichia coli. To test the interaction of this
dimer with Def1, pure recombinant Def11–500, mimicking the
active pr-Def1 fragment, was immobilized on beads. A similar
amount of the corresponding CUE mutant was also immobilized
(Figure 5E). Remarkably, although the recombinant, purified
Ela1-Elc1 complex was not ubiquitylated, it associated with
immobilized Def11–500, but not when the CUE domain was
mutated (Figure 5E, compare lanes 6 and 7).
To further investigate whether Def1 bridges or stabilizes an
interaction between RNAPII and the Elongin-Cullin complex,
we used purified RNAPII, Def1, and recombinant Ela1-Elc1 com-
plex in tripartite binding experiments (Figure 5F). In these exper-
iments, RNAPII was immobilized on beads. Both Def11–500 and
Def11–500/CUEm bound to such beads, but showed only back-
ground binding to the empty control beads (Figure 5F, compare
lanes 6 and 8 with 5 and 7, respectively). In contrast, Ela1-Elc1
complex bound poorly to RNAPII (Figure 5F, compare lanes 9
and 10). However, when Def1 was included in the binding reac-
tion, a strong association of Ela1-Elc1 complex with RNAPII was
detected (Figure 5F, compare lanes 10 and 12). Importantly, the
ability of Def1 to bridge the interaction between RNAPII and
Ela1-Elc1 was dependent on the CUE domain: even though
Def11–500/CUEm associated with RNAPII-containing beads as
efficiently as its WT counterpart, it had little or no stimulating
effect on Ela1-Elc1 binding (Figure 5F, compare lanes 12 and
14 with lane 10). Interestingly, addition of Ela1-Elc1 also clearly
increased Def1-RNAPII interaction (Figure 5F, compare Def1
binding in lane 12 with that in 6, 8, and 14), thus contributing to
a more stable RNAPII/Def1/Ela1-Elc1 ternary complex.
A Functionally Important Ubiquitin-Homology Domain in
the Ela1 Protein
Recombinant Ela1-Elc1 complex interacts directly with Def1 in a
CUE (ubiquitin-binding domain [UBD])-dependent manner, sug-
gesting that, per definition, Ela1 or Elc1 must contain a domain
that resembles ubiquitin, e.g., a ubiquitin homology domain
(UbH). Indeed, Ela1-Elc1 complex was also capable of associ-
ating with other purified UBD proteins or domains, such as
Dsk2, RAP80, and Ataxin-3 (Dikic et al., 2009) (Figure 6A,
compare lanes 4–6 with lanes 2 and 3). Interestingly, however,
only Def1 retrieved Ela1-Elc1 from crude yeast extracts, but
did not bind ubiquitylated proteins. Conversely, Dsk2, Rap80,
and Ataxin-3 bound ubiquitylated proteins, but did not bind
Ela1-Elc1 under the same conditions (Figure S6A). This indicates
that Def1’s CUE domain specifically interacts with Ela1-Elc1
through the putative UbH, but does not generally bind ubiquity-
lated proteins.adiation. Image below shows enlargement of yeast cell indicated by white box.
on the left) grown on glucose or galactose.
GFP-b-galactosidase (panels g–l), or NLS-GFP-Def1500–738 (panels m–r), in WT
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Figure 5. TheCUEDomain of Def1 Is Essen-
tial for Rpb1 Polyubiquitylation
(A) Top: schematic of Def1 showing four key
mutated residues of the CUE domain. Bottom:
dilution series of Ddef1 cells (carrying the GAL-
driven CEN plasmid indicated on the left), grown
on glucose or galactose.
(B) Western blot of extracts fromWT, def1CUEm, or
Ddef1 cells, UV-irradiated at time 0. Ubiquitylated
Rpb1 isolated by MultiDsk pull-down. Asterisk
denotes an additional band occasionally observed
with the anti-Def1 antibody. Superfluous lanes
between lanes 4 and 5 were removed.
(C) Western blot of Myc-Def1 and Myc-Def1CUEm,
immunoprecipitated from extracts prepared 1 hr
after UV irradiation. Recombinant Ela1 is loaded
as an antibody specificity control (lane 1).
(D) Western blot of Myc-Elc1 immunoprecipitated
from chromatin-enriched extracts from WT or
Def1CUEm cells, prepared 1 hr after UV irradiation.
(E) Binding of recombinant Ela1-Elc1 heterodimer
to immobilized, recombinant Def11–500 or
Def11–500/CUEm (seealsoFigureS3A).Proteinswere
separated by SDS-PAGE and stained with silver.
(F) Western blot analyzing binding of recombinant
Ela1-Elc1 heterodimer to immobilized RNAPII (or
empty control beads), in the absence or presence
of recombinant Def11-500, or Def11-500/CUEm.
Schematics of results are shown below the rele-
vant lanes.
See also Figure S5.Given that Elc1 is a very small, Skp1-like polypeptide (Fig-
ure 6B, lower), it seemed unlikely to contain a UbH. In contrast,
Ela1 is significantly larger (upper), and the function of its C-termi-
nal domain was unclear, prompting us to investigate this region.
Constructs encoding different C-terminally truncated Ela1 forms
(Figure 6C, schematic on right) were coexpressed with Elc1 in
bacteria, and the resulting complexes purified and tested for
their ability to bind Def1 immobilized on beads (Figure 6C,
left). As expected from previous work (Koth et al., 2000), the
different Ela1 forms were all capable of forming a complex
with Elc1 (Figure 6C, lanes 1, 4, 7, and 10). However, Ela1-
Elc1 complexes that only contained the first 250 or 300 amino
acids of Ela1, respectively, were unable to bind Def1 beads (Fig-
ure 6C, compare lanes 3 and 6 with lanes 9 and 12). Moreover,
the Ela1 C-terminal region was not only required, but also990 Cell 154, 983–995, August 29, 2013 ª2013 The Authorssufficient for association with purified
Def11–500 (Figure 6D, compare lane 5
with lanes 2 and 3).
These data prompted us to per-
form an alignment of ubiquitin with the
Ela1 C-terminal domain required for
Def1 binding (Figure S6B), which further
supported the finding that Ela1 con-
tains a UbH. Ela11–250 also interacted
with Elc1 inside cells (Figure S6C)
but failed to support damage-induced
ubiquitylation (Figure 6E) and degrada-
tion of Rpb1, similar to a strain lackingELA1 altogether (Figure 6F, compare lanes 1–6 with 7–12 and
13–18, respectively), indicating that the UbH is important
for cellular Ela1 function.
Together, these results indicate that Def1 bridges the interac-
tion between RNAPII and the Elongin-Cullin ubiquitin ligase com-
plex via an interaction between its CUE domain and a UbH in the
Ela1 subunit of the Ela1-Elc1 adaptor complex.
DISCUSSION
The process leading to disassembly of RNAPII elongation com-
plexes in response to transcription stress is remarkable by
encompassing so many disparate ubiquitin-based events. For
example, Def1 is partially processed, but not entirely degraded,
via a ubiquitin-directed, proteasome-dependent mechanism.
Figure 6. The CUE Domain of Def1 Binds
Ela1-Elc1
(A) Western blot to detect binding of recombinant
Ela1-Elc1 heterodimer to immobilized, recombi-
nant Def11–500 and Dsk2, or the ubiquitin-binding
domains from Rap80 and Ataxin-3. See also Fig-
ures S3A and S6A.
(B) Schematic of Ela1 and Elc1, indicating relevant
domains.
(C) Binding of recombinant Ela1-Elc1 hetero-
dimers (Ela1 form schematically depicted on the
right) to immobilized, recombinant Def11–500 (Def),
or control beads (C). Protein gel stained with sil-
ver. Asterisk indicates a contaminating protein
from the purification of full-length Ela1-Elc1
complex.
(D) Western blot showing binding of purified, re-
combinant Def11–500 to immobilized GST-fusion
proteins, including GST-Ela1250–379. Ponceau S
stain of membrane shown as a loading control for
GST-fusion proteins.
(E) MultiDsk pull-down, comparing damage-
induced Rpb1 ubiquitylation in WT Ela1 (Ela1 WT)
and cells lacking Ela1’s UbH (ela11–250).
(F) As in (E), but comparing total Rpb1 levels after
DNA damage.Def1 also contains a ubiquitin-binding domain (UBD), but this
domain does not have a ubiquitin-moiety as its primary target.
Rather, it binds to a ubiquitin homology (UbH) domain in the
Ela1 subunit of the yeast Elongin adaptor complex. This allows
recruitment of the Elongin-Cullin E3 complex to RNAPII, which
in turn results in Rpb1 becoming polyubiquitylated and degraded
by the proteasome.
Proteasomal Processing and Activation of Def1
Several general principles of proteasome-mediated protein
processing have emerged through the study of mammalian
NF-kB proteins and their yeast homologs, Mga2 and Spt23
(Rape and Jentsch, 2002). For example, proteasomal processingCell 154, 983–995, August 29, 2013 ª2013 The Authors 991.
,typically involves ubiquitylation of the
target protein, although not necessarily
polyubiquitin chains: monoubiquitylation
can be sufficient to elicit or speed up
the reaction (Rape et al., 2001; Kravt-
sova-Ivantsiv et al., 2009). Similar results
are reported here: proteasomal Def1 pro-
cessing is greatly stimulated by, but does
not absolutely require, monoubiquityla-
tion. Remarkably, the reaction can even
be reconstituted with purified proteins:
incubation of highly purified Def1 with
highly purified proteasome results in cor-
rect processing. This suggests that all
signals for this intriguing process may
be intrinsic to the factors involved, e.g.,
that it does not require another protease
to perform the initial ‘‘protein nicking,’’
or accessory factors to help stop the pro-teasome from completely degrading the target. The fully defined
Def1 processing system should prove helpful in further defining
the underlying mechanisms.
At the cellular level, our data are consistent with a model, in
which Def1 constantly shuttles in and out of the nucleus, but is
predominantly found in the cytoplasm at steady state; this is
dependent on the C-terminal region of the protein. Def1 pro-
cessing removes this region, allowing nuclear accumulation
As far as we know, Def1 represents the first example of a protein
in which nuclear accumulation occurs as a result of regulated
proteolytic removal of a domain that directs cytoplasmic trans-
port. We note that studies on proteins such as Huntingtin and
Ataxin-7 have indicated that polyglutamine domain expansion
observed in disease-causing versions of these proteins affects
subcellular localization (Nucifora et al., 2001; Chan et al.,
2011). Further studies are needed to understand the details of
Def1 subcellular transport, but it is an intriguing possibility that
the extremely glutamine-rich regions in the C-terminal half of
the protein also somehow regulate nucleocytoplasmic transport
in the case of Def1.
Ubiquitylation and degradation of Rpb1 is used as a last-resort
response to a variety of conditions, frequent or infrequent, that
result in transcription stress (Bregman et al., 1996; Somesh
et al., 2005; Sigurdsson et al., 2010; Hobson et al., 2012). Given
that the C-terminal domain of Def1 promotes cytoplasmic local-
ization, it is possible that Def1 normally shuttles in and out of the
nucleus so that at least a small amount of Def1 is present in the
nucleus at all times. In this scenario, the predominant cyto-
plasmic location of Def1 ensures that it is normally limiting for
Rpb1 polyubiquitylation, helping to restrict Rpb1 degradation
to a last resort solution to normal transcription elongation prob-
lems. Upon DNA damage or other genome-wide transcription
stress, however, the protein is allowed to temporarily accumu-
late in the nucleus, so that RNAPII can be rapidly cleared and
transcription restarted. Def1 ubiquitylation by Rsp5, as well as
its processing by the proteasome, might occur in the nucleus,
possibly even triggered at the stalled polymerase, but this re-
mains to be determined.
Interestingly, Def1 is involved in a number of other, apparently
unrelated cellular processes (Chen et al., 2005; Jordan et al.,
2007; Suzuki et al., 2011), opening the possibility that other path-
waysmight also rely onDef1 for their proper activationor inactiva-
tion in response to DNA damage and other stress. We note that
the Def1 pathway has interesting parallels with the bacterial
SOS response, as well as with metazoan apoptosis. In the bacte-
rial SOS response, DNA damage results in the RecA-dependent
autocatalytic clipping of the LexA repressor protein, resulting in
upregulationof repair genes andallowingmutation-prone survival
in the face of severe DNA damage (Schlacher and Goodman,
2007). In mammalian cells, severe DNA damage can elicit
apoptosis by triggering the protease (caspase)-dependent cleav-
age and inactivation of ICAD/DFF45 to allow the nuclease CAD to
enter the nucleus and fragment the DNA (Nagata, 2000).
Proteolytic processing-dependent release of protein fragments,
whose activity needs to be restricted to a severe cellular crisis sit-
uation,may thushavebeenutilizedseveral timesduringevolution.
The Multiple Steps of Rpb1 Ubiquitylation and
Degradation
Rpb1 ubiquitylation and degradation occurs via a complex,
multistep mechanism (Wilson et al., 2013). In the initial step,
Rpb1 is monoubiquitylated by Rsp5, before another E3, the
Elongin-Cullin complex, takes over to perform polyubiquitylation
(Figure 7, steps 1 and 4, respectively). Our data show how Def1
fits into this complex scheme: it is activated by Rsp5-mediated
ubiquitylation, which allows its proteasomal processing and
nuclear accumulation (step 2), so that Def1 can bind RNAPII
and help recruit the Elongin-Cullin complex, promoting efficient
polyubiquitylation (steps 3 and 4). Intriguingly, Def1 contains a
CUE domain (UBD), shown here to be essential for this function.
Interestingly, this domain is not used to bind the monoubiquity-992 Cell 154, 983–995, August 29, 2013 ª2013 The Authorslated polymerase, but rather to recruit the Elongin-Cullin com-
plex. Indeed, we found that the Ela1 subunit of the Elongin
adaptor complex harbors a UbH. In humans, the related Elongin
A complex comprises three subunits, Elongin A, B, and C (Aso
et al., 1995). Budding yeast only has homologs of Elongin A
(Ela1) and Elongin C (Elc1) (Koth et al., 2000). Remarkably, the
small human Elongin B protein, which lacks a yeast homolog,
contains a UbH (Garrett et al., 1995). Given that yeast Ela1 har-
bors a UbH in its C terminus (that is not conserved in mammalian
Elongin A), it is an obvious possibility that sequences encoding
this domain have become separated onto a separate gene, en-
coding Elongin B, during evolution. Our data provide evidence
for an important role for this UbH in protein ubiquitylation.
More specifically, we show that Elongin’s UbH plays a role in
mediating target recognition, rather than, for example, mediating
proteasome delivery as has previously been hypothesized
(Welchman et al., 2005). We note that, as is true for all proteins
containing a ubiquitin-binding domain or a ubiquitin-homology
domain (Hofmann, 2009), binding specificity must occur through
combination with other recognition domains and motifs in Def1
and the Elongin-Cullin complex.
The Elongin complex is akin to the Skp1/F-box proteins of
other Cullin-ligases (Koth et al., 2000). These proteins are
substrate-specific adaptors, which mediate correct target
recognition. Ela1/Elc1 complex is unusual in that this adaptor
does not actually recognize its target protein, RNAPII, but rather
the bridging factor Def1, which then connects it to the target (Fig-
ure 7B). The APC/C complex, a Cullin-like ligase, employs
distinct substrate-specificity factors (e.g., Cdc20 and Cdh1),
but these are integral components of the complex in specific
phases of the cell cycle (Bassermann et al., 2013). In contrast,
Def1, to the best of our knowledge, represents the first example
of a discrete bridging factor being required for target recognition
by a Cullin E3 ligase.Whether substrate-specific bridging factors
are required for the diverse functions of Elongin-Cullin com-
plex(es), and for Cullin-type E3 ligases in general, is an intriguing
possibility that deserves further investigation.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
Tables S1 and S2 describe S. cerevisiae strains and plasmids. Standard tech-
niques were employed for their construction.
In Vivo Techniques
Whole-cell extracts were prepared by alkaline extraction (Kushnirov, 2000) or
via bead-beating, with ubiquitylated proteins being isolated using MultiDsk
resin (Wilson et al., 2012). A list of antibodies used in this study can be found
in Table S3.
In Vitro Assays
Def1 ubiquitylation assays were performed essentially as described for RNAPII
ubiquitylation (Somesh et al., 2005). Binding experiments were performed
largely as described (Anindya et al., 2010). Reconstituted proteasome assays
were performed with purified yeast proteasome (10 nM) and Def1 (1.5 mM) in
reactions with and without MG132 (10 mM).
Fluorescence microscopy was carried out on live cells or in formaldehyde-
fixed cells (Figures 4E and S4B). Deltavision microscopy was used to visualize
yeast using an X100 UplanSApo 1.40 NA oil objective lens on an Olympus in-
verted microscope (IX71).
For further details, please see the Extended Experimental Procedures.
Figure 7. Model for Def1 Function
(A) Model for Def1-dependent polyubiquitylation of Rpb1. (1) Rsp5 monoubiquitylates Rpb1. (2) Concurrently, Rsp5 ubiquitylates Def1, resulting in proteasomal
processingandnuclearaccumulation. (3)Nuclearpr-Def1bindsRNAPII, (4) recruitingElongin-Cullincomplex tocarryoutRpb1polyubiquitylation.See text fordetails.
(B) Schematic depicting the bridging function of Def1. Ela1-Elc1 complex may also have weak Def1-independent interactions with RNAPII, as suggested by the
findings of Figure 5F.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2013.07.028.
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